— Know what they know.
Not Investment Advice

KALY OTC

Kali, Inc.
1W: +0.0% 1M: +9900.0% 3M: +0.0% YTD: +100.0% 1Y: +100.0% 3Y: +999900.0% 5Y: +90809.1%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 55 · $101824 mcap · 771M float · 0.034% daily turnover · Short 41% of daily vol

Income Trends

Revenue
$65K -3.4% ▼
5Y CAGR: -76.4%
Gross Profit
$14K -22.9% ▼
5Y CAGR: -79.4%
Operating Income
-$12K -27.8% ▼
Net Income
-$12K -27.9% ▼
EPS (Diluted)
$-0.00 +26.3% ▲
EBITDA
-$12K -27.8% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2012FY2015FY2016FY2017FY2018
Revenue$95M$84K$72K$68K$65K
YoY Growth+6.4%+0.0%-14.4%-5.5%-3.4%
Cost of Revenue$52M$0$70K$49K$51K
Gross Profit$42M$84K$1K$19K$14K
Gross Margin44.5%100.0%1.9%27.6%22.0%
R&D Expenses$0$0$0$0$0
SG&A Expenses$18M$89K$0$28K$26K
Operating Expenses$18M$89K-$3$28K$26K
Operating Income$24M-$5K$1K-$9K-$12K
Operating Margin25.5%-6.1%1.9%-13.8%-18.2%
Interest Expense$0$0$0$0$0
Income Before Tax$25M-$5K$1K-$9K-$12K
Tax Expense$7M$0$0$0$0
Net Income$18M-$5K$1K-$9K-$12K
Net Margin18.5%-6.1%1.9%-13.8%-18.2%
EPS (Diluted)$6.78$-0.00$0.00$-0.00$-0.00
EBITDA$26M-$5K$1K-$9K-$12K
Shares Outstanding3M14M285M587M1.02B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms